Preeclampsia 1

Uzan J et al. (2011) Pre-eclampsia: pathophysiology, diagnosis, and management.

Laasanen J et al. (2002) Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia.

Maynard SE et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

None (2003) The genetics of pre-eclampsia: a feto-placental or maternal problem?

Faisel F et al. (2004) Susceptibility to pre-eclampsia in Finnish women is associated with R485K polymorphism in the factor V gene, not with Leiden mutation.

Levine RJ et al. (2004) Circulating angiogenic factors and the risk of preeclampsia.

Cnattingius S et al. (2004) Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: a population-based Swedish cohort study.

None (2005) Disentangling fetal and maternal susceptibility for pre-eclampsia: a British multicenter candidate-gene study.

Uz E et al. (2007) Extremely skewed X-chromosome inactivation is increased in pre-eclampsia.

Kanasaki K et al. (2008) Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia.

Berends AL et al. (2008) Familial aggregation of preeclampsia and intrauterine growth restriction in a genetically isolated population in The Netherlands.

Zhou CC et al. (2008) Angiotensin receptor agonistic autoantibodies induce pre-eclampsia in pregnant mice.

Payne B et al. (2011) Assessment, surveillance and prognosis in pre-eclampsia.

Wallukat G et al. (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.

van Dijk M et al. (2012) HELLP babies link a novel lincRNA to the trophoblast cell cycle.

Oudejans CB et al. (2015) Susceptibility allele-specific loss of miR-1324-mediated silencing of the INO80B chromatin-assembly complex gene in pre-eclampsia.

Cooper DW et al. (1979) Genetic control of severe pre-eclampsia.

Hayward C et al. (1992) An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance.

Liston WA et al. (1991) Is genetic susceptibility to pre-eclampsia conferred by homozygosity for the same single recessive gene in mother and fetus?

Wilton AN et al. (1990) Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA DR beta.

Arngrimsson R et al. (1990) Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population.

Kilpatrick DC et al. (1989) Association between susceptibility to pre-eclampsia within families and HLA DR4.

None (1988) Genetics of pre-eclampsia.

Davey DA et al. (1988) The classification and definition of the hypertensive disorders of pregnancy.

Cooper DW et al. (1988) Genetic control of susceptibility to eclampsia and miscarriage.

Chesley LC et al. (1986) Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women.

Zusterzeel PL et al. (2001) A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia.

Hillermann R et al. (2005) The Glu298Asp variant of the endothelial nitric oxide synthase gene is associated with an increased risk for abruptio placentae in pre-eclampsia.

Zusterzeel PL et al. (1999) Glutathione S-transferase isoenzymes in decidua and placenta of preeclamptic pregnancies.

Zusterzeel PL et al. (2002) Paternal contribution to the risk for pre-eclampsia.

Hiby SE et al. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success.

Chesley LC et al. (1968) The familial factor in toxemia of pregnancy.

None (1980) Genetic control of pre-eclampsia.

Fisher KA et al. (1981) Hypertension in pregnancy: clinical-pathological correlations and remote prognosis.

Van Meter TD et al. (1993) Concerns about the genetics of pre-eclampsia.

Brenner B et al. (1996) HELLP syndrome associated with factor V R506Q mutation.

Harrison GA et al. (1997) A genomewide linkage study of preeclampsia/eclampsia reveals evidence for a candidate region on 4q.

Sohda S et al. (1997) Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia.

Arngrímsson R et al. (1997) Evidence for a familial pregnancy-induced hypertension locus in the eNOS-gene region.

Lindqvist PG et al. (1998) Factor V Q506 mutation (activated protein C resistance) associated with reduced intrapartum blood loss--a possible evolutionary selection mechanism.

Kupferminc MJ et al. (1999) Increased frequency of genetic thrombophilia in women with complications of pregnancy.

Thornton JG et al. (1999) Twin mothers, pregnancy hypertension and pre-eclampsia.

Arngrímsson R et al. (1999) A genome-wide scan reveals a maternal susceptibility locus for pre-eclampsia on chromosome 2p13.

Rajkovic A et al. (2000) Methylenetetrahydrofolate reductase 677 C --> T polymorphism, plasma folate, vitamin B(12) concentrations, and risk of preeclampsia among black African women from Zimbabwe.

Napolitano M et al. (2000) Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas.

Page NM et al. (2000) Excessive placental secretion of neurokinin B during the third trimester causes pre-eclampsia.

Brown MA et al. (2000) The detection, investigation and management of hypertension in pregnancy: full consensus statement.

Moses EK et al. (2000) A genome scan in families from Australia and New Zealand confirms the presence of a maternal susceptibility locus for pre-eclampsia, on chromosome 2.

Roberts JM et al. (2001) Pathogenesis and genetics of pre-eclampsia.

Esplin MS et al. (2001) Paternal and maternal components of the predisposition to preeclampsia.

Lachmeijer AM et al. (2001) A genome-wide scan for preeclampsia in the Netherlands.

OMIM.ORG article